Search
Heliomycin
go.drugbank.com/drugs/DB20233ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Heliomycin is a antibiotic, produced by Streptomyces strain. Heliomycin has a monoisotopic molecular weight of 376.09 Da.
Nogalamycin
go.drugbank.com/drugs/DB20882ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Nogalamycin is a antibiotic, produced by Streptomyces strain. Nogalamycin has a monoisotopic molecular weight of 787.31 Da.
Myrcludex B
go.drugbank.com/drugs/DB14853InvestigationalWith Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D). … Myrcludex B is under investigation in clinical trial NCT03546621 (A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination
Brofaromine
go.drugbank.com/drugs/DB13876ExperimentalCategories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome2,5-Dimethoxy-4-ethylthioamphetamine
go.drugbank.com/drugs/DB13940Experimental2,5-Dimethoxy-4-ethylthioamphetamine (ALEPH-2) is a phenylisopropylamine derivative with alleged anxiolytic and hallucinogenic properties.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeSedecamycin
go.drugbank.com/drugs/DB21342ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Sedecamycin is a antibiotic, produced by Streptomyces strain. Sedecamycin has a monoisotopic molecular weight of 501.24 Da.
Bicozamycin
go.drugbank.com/drugs/DB20821ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Bicozamycin is a antibiotic, produced by Streptomyces strain. Bicozamycin has a monoisotopic molecular weight of 302.11 Da.
Streptonigrin
go.drugbank.com/drugs/DB19689ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Streptonigrin is a antibiotic, produced by Streptomyces strain. Streptonigrin has a monoisotopic molecular weight of 506.14 Da.
Synonyms: Antibiotic produced by streptomyces flocculusFontolizumab
go.drugbank.com/drugs/DB05111InvestigationalFontolizumab (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.
Ademetionine
go.drugbank.com/drugs/DB00118ApprovedInvestigationalNutraceuticalPhysiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)